Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells  by Kessner, Stephan et al.
Investigation of the cellular uptake of E-Selectin-targeted
immunoliposomes by activated human endothelial cells
Stephan Kessner a, Annett Krause a, Ulrich Rothe b, Gerd Bendas a;*
a Department of Pharmacy, Martin-Luther-University Halle, Wolfgang-Langenbeck-Strasse 4, D-06120 Halle, Germany
b Institute of Physiological Chemistry, Martin-Luther-University Halle, Hollystrasse 1, D-06097 Halle, Germany
Received 13 February 2001; received in revised form 5 June 2001; accepted 20 June 2001
Abstract
In the present study the cellular uptake of targeted immunoliposomes by interleukin-1 activated human endothelial cells
has been analysed by several spectroscopical and microscopical fluorescence techniques. Previous in vitro experiments
demonstrated that the targeting of immunoliposomes to vascular selectins is a potential way for a selective drug delivery at
inflammatory sites. In attempts to further adapt the targeting experiments to physiological conditions, we demonstrate that
E-Selectin-directed immunoliposomes are able to bind their target cells under the simulated shear force conditions of
capillary blood flow cumulatively for up to 18 h. In order to consequently follow the fate of liposomes after target binding,
we analysed the route and degree of liposome internalization of the cells concentrating on cell activation state or various
liposomal parameters, e.g., sterical stabilization, type of antibody or antibody coupling strategy. The use of NBD-labelled
liposomes and subsequent fluorescence quenching outside the cells with dithionite show that circa 25% of the targeted
immunoliposomes were internalized. According to inhibition experiments with agents that interfered with the endocytotic
pathway, we found out that the major mechanism of liposome entry is endocytic. The entry involves, at least in part,
receptor-mediated endocytosis via E-Selectin, a liposome accumulation in the endosomes and their acidification was proved
by pyranine spectroscopic results. Furthermore, microscopical investigations demonstrate that also a fusion of liposomes
with the cell membrane occurs followed by a release of entrapped calcein into the cytoplasm. These observations gain insight
into the behaviour of E-Selectin-targeted immunoliposomes and indicate that these immunoliposomes have great potential to
be used as drug carriers for intracellular drug delivery at inflammatory sites. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The site-speci¢c drug delivery to cells or organs is
a potentially attractive mode of therapy for increas-
ing the therapeutic e⁄ciency of drugs and reducing
their toxicity. Liposomes, especially antibody-tar-
geted liposomes, also referred to as immunolipo-
somes (IL) have been regarded as very promising
drug targeting vehicles [1^3]. A variety of techniques
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Abbreviations: Chol, cholesterol ; EDC, 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide; HPTS, 8-hydroxypyrene-1,3,6-trisul-
fonate; HUVEC, human umbilical vein endothelial cells ; IL, im-
munoliposomes; mAb, monoclonal antibody; NBD-PE, 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) ; N-Glut-PE, N-glutaryl-phosphatidylethanol-
amine; PEG, poly(ethylene glycol) ; PBS, phosphate-bu¡ered sa-
line; SPC, soy phosphatidyl choline
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exist for the preparation of IL which di¡er in their
strategies for the antibody coupling onto the lipo-
somes. It could be shown that the sterical stabiliza-
tion of liposomes by polyethylene glycol (PEG), in
order to avoid rapid removal from the circulation,
can be combined e¡ectively with antibody coupling
[4,5]. Principally, two types of sterically stabilized IL
exist: (i) conventional IL with antibodies directly
coupled onto the liposomal surface in the presence
of PEG [6,7] and (ii) IL with antibodies coupled onto
the terminal ends of the grafted PEG-chains [8^10].
The latter could be demonstrated to be more advan-
tageous for targeting because of its exposed accessi-
ble and £exible antibody position.
The most attractive therapeutic IL application has
been in the ¢eld on chemotherapeutic cancer treat-
ment [11]. Furthermore, the site-speci¢c treatment of
in£ammatory diseases by targeting liposomes to vas-
cular adhesion receptors that normally mediate the
recruitment and extravasation of leukocytes to in-
£amed tissues is of growing interest [12]. Among
these adhesion receptors, E-Selectin seems to be the
most attractive candidate for targeting since its ex-
pression is strictly time and spatial in relationship to
the in£ammation. E-Selectin is a transmembrane gly-
coprotein which is expressed by de novo synthesis in
response to in£ammatory mediators like interleukin-
1 or tumour necrosis factor K in a time course of
4^24 h after activation [13]. Various studies demon-
strated the involvement of an E-Selectin expression
in several pathological in£ammatory diseases such as
rheumatoid arthritis, myocardial ischaemia or athe-
rosclerosis [14,15]. A few studies reported on the
successful targeting of liposomes or IL to E-Selectin
in order to create anti-in£ammatory directed drug
targeting vehicles [16,17].
An accumulation of liposomes at the target site is
a prerequisite, but does not in itself mediate a ther-
apeutical e¡ect of the encapsulated drugs. Therefore,
the speci¢c mode of liposome cell interaction has to
be considered. In principle, these kinds of interac-
tions are not to be generalized, but depend on vari-
ous factors such as the kind and activation of the
target cells and on several liposomal parameters
like particle size, charge, sterical stabilization and
speci¢c characteristics of the homing devices. A cel-
lular uptake of the liposomes is mostly required since
most drugs act intracellularly, and liposomal gene
therapy with the desired delivery of oligonucleotides
or genes is of growing importance. The cellular in-
corporation of liposomal content can occur in di¡er-
ent ways, namely (i) as the uptake of the soluble
content which was released from the liposomes out-
side the cell, (ii) as a result of liposomal fusion within
the cell membrane followed by an intracellular re-
lease of the liposomal content and (iii) by an active
uptake of the liposomes on an endocytotic path-
way.
In previous studies, we demonstrated the target
binding of IL at E-Selectin-expressing cells [17] and
we have continued doing these experiments with hu-
man umbilical vein endothelial cells (HUVEC). As
we were able to demonstrate in this study that IL
bind E-Selectin under simulated shear force condi-
tions of capillary blood £ow for a circulation and
therapy relevant time of up to 18 h, we chose as
our main intention of this study to analyse a possible
cellular uptake of the targeted IL. There can be no
prediction as to whether or not the liposomes will be
taken up at all and which way will be the preferred
one, because only few studies exist that dealt with
liposome uptake by endothelial cells, which could
rarely be compared due to the di¡erent origin of
the endothelial cells [18^21]. Furthermore, various
experimental techniques exist to prove an uptake of
liposomes or liposomal compartments, which in most
cases detect only one possible mode of internaliza-
tion. Research indicates that to date no direct com-
parison of all these techniques applied to a certain
liposome cell system has been done.
In the present study, we applied di¡erent spectro-
scopical and microscopical £uorescence techniques to
investigate the way and the degree of internalization
of E-Selectin-targeted IL by HUVEC. Since we de-
tected that certain amounts of liposomes are taken
up by di¡erent ways, our results are discussed in the
context of targeted drug delivery focusing on E-Se-
lectin’s active role in internalization and to liposomal
parameters. In addition, the parallel application of
four di¡erent £uorescence techniques should further
allow a characterization of analytical values and lim-
itations of the individual techniques.
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2. Materials and methods
2.1. Materials
Soy phosphatidylcholine (SPC) was obtained from
Lucas Meyer (Hamburg, Germany). Antimycin A,
cholesterol, 1-ethyl-3-(3-dimethylaminopropyl)carbo-
diimide (EDC), sodium hydrosul¢te (dithionite), cal-
cein, cytochalasin D and 8-hydroxypyrene-1,3,6-tri-
sulfonate (HPTS) were purchased from Sigma
(Deisenhofen, Germany). Polyethylene glycol-PE
(PEG-PE 2000), Lissamine Rhodamine-PE and 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(7-
nitro-2-1,3-benzoxadiazol-4-yl) (NBD-PE) were pur-
chased from Avanti Polar Lipids (Alabaster,
AL, USA). The substances were used without fur-
ther puri¢cation. The membrane anchors for anti-
body coupling Cyanur-PEG-PE and N-Glut-PE
were synthesized in our group as previously de-
scribed [22]. All salts and bu¡ers were of analytical
grade.
The murine anti (human) E-Selectin mAb (BBA
26) was purchased from RpD Systems (Wiesbaden,
Germany).
2.2. Preparation of IL
Large unilamellar vesicles (LUV) were prepared by
extruding multilamellar vesicles. For this purpose, a
lipid ¢lm (10 Wmol) was suspended in 1 ml aqueous
solution (bu¡er, NaCl or 100 mM calcein) at 60‡C.
The resulting multilamellar vesicles were extruded six
times (Extruder, Lipex Biomembrane, Vancouver,
Canada) subsequently through a 100-nm and 50-nm
polycarbonate membrane (Costar, Bodenheim, Ger-
many). Vesicle size of around 70 nm was determined
by dynamic light scattering using a Malvern Auto-
sizer II c (Malvern, UK) in mass distribution mode.
The lipid composition of vesicles was modi¢ed ac-
cording to the coupling procedure. The basic lipid
composition was SPC/Chol 2:1 (molar ratio), where-
by either 5 mol% N-Glut-PE or 5 mol% Cyanur-
PEG-PE were incorporated to prepare IL. The addi-
tion of PEG-PE 2000 diminished the fraction of
SPC. Likewise, for £uorescence detection 2 mol%
NBD-PE were incorporated in all vesicle prepara-
tions.
For all coupling procedures, an initial phospho-
lipid/Ab molar ratio of 1000:1 was chosen, as previ-
ously optimized by Hansen et al. [7]. The cou-
pling yield of all reactions was quanti¢ed with a
protein determination assay according to Peterson
and Lowry [23] and correlated to the actual lipo-
some concentration detected by phosphate assay
[24].
Liposomes containing Cyanur-PEG-PE were pre-
pared in 0.15 M NaCl. The indicated amounts of
antibodies, which were dissolved in borate bu¡er to
adjust to a pH of 8.8 were added to this preparation
and incubated at room temperature for about 16 h.
Unbound antibodies were separated by passing the
liposomes over a Sepharose 4B (Sigma) column and
eluting them with PBS, pH 7.4.
To form a protein linkage to liposomal N-Glut-
PE, 6 mg EDC was added to 10 Wmol liposomes in
PBS (pH 7.4) followed by an incubation period of at
best 6 h at RT and by gel permeation chromatogra-
phy (Sephadex G50, Pharmacia, Sweden) to remove
excess EDC. Antibodies were added and incubated
overnight at room temperature. The IL were sepa-
rated from unbound antibodies by gel permeation
chromatography by using Sepharose 4B.
2.3. Cell cultivation and cell-related materials
Human endothelial cells from umbilical cords
(HUVEC) were used as target cells. HUVEC were
isolated and cultured in medium 199 with Earle’s
salts (Gibco BRL) supplemented with 20% foetal
calf serum, 1% penicillin/streptomycin, 1% essential
amino acids (all c.c.pro GmbH, Germany) and 1%
1mM HEPES (pH 7.4).
Flasks seeded with freshly isolated HUVEC were
incubated at 37‡C in 5% CO2 for approx. 4 days
until cells were grown nearly con£uent. Passage 2
or 3 cells were used for the experiments.
For comparison, HPTS endocytosis assay was per-
formed with two further cell lines. Keratinocytes
(HaCat), which were used as negative control were
a kind gift from Professor Wohlrab, University of
Halle. Cells were cultivated in Keratinocyte SFM
(Gibco BRL) at 37‡C in 5% CO2 for 4^5 days. A
murine macrophage cell line (J 774, ATCC) was a
much appreciated gift from Professor Schro«der, De-
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partment of Pharmacy, University of Halle. Cells
were grown in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% PBS and 1% penicillin/strep-
tomycin at 37‡C in 5% CO2 until the cells were
nearly con£uent.
2.4. Cell-binding studies
2.4.1. Liposome binding under static conditions
For binding studies, 96-well plates (BMG Labsys-
tems) coated with 1% gelatine were seeded with
nearly 40 000 HUVEC per well and incubated at
37‡C in 5% CO2 for 3 h until the cells formed a
stable monolayer at the well bottom. Afterwards,
3 h before liposome addition HUVEC were activated
with recombinant human interleukin-1L (10 ng/ml
medium, E-coli, Boehringer Mannheim, Germany)
at 37‡C. After an exchange of the medium, liposomes
containing NBD-PE were added (150 nmol/well) fol-
lowed by an incubation of over 60 min at 4‡C before
replacing unbound liposomes, this was done by
washing three times with PBS and £uorimetric detec-
tion (Fluostar Galaxy, BMG).
2.4.2. Liposome binding under simulated shear force
conditions
The dynamic liposome-binding experiments were
performed in a laminar £ow chamber as previously
described [17] with slight modi¢cations. The poly-
acrylic device contains two £ow chambers one be-
neath the other at the bottom. The chambers can
be closed by round microscope slides (18 mm diam-
eter), which were coated with ca. 500 000 HUVEC
(incubation 3 h at 37‡C, gelatine-coated 0.5%). The
chambers allow the HUVEC layers to be rinsed with
a bu¡er containing the liposomes (corresponding to
2 Wmol/106 cells) for several hours at shear force
conditions that simulate the capillary blood £ow
(shear rate of about 200 s31) by connecting a peri-
staltic pump. To detect the liposome-binding events
at the HUVEC layer, the laminar £ow chamber was
mounted on the stage of an inverted laser scanning
microscope (LSM 410 invert, Carl Zeiss) in combi-
nation with a £uorescent microscope Axiovert 135.
In order to get an internal negative control for the
binding experiments, HUVEC on one slide were al-
ways activated by interleukin-1L (3 h) while the
HUVEC on the other slide were not.
2.5. Detection of an immunoliposome uptake by
HUVEC
2.5.1. Dithionite technique
The chemical basis of the dithionite technique is
the quenching of liposomal NBD-£uorescence,
achieved by chemically reducing NBD into the cor-
responding amino derivative which in turn is caused
by dithionite. A prerequisite for this is the use of
targeted liposomes which contain NBD-PE only in
the outer monolayer. Therefore, liposomes were pre-
pared as described (see Section 2.2) and NBD-PE
(2 mol%) was added to the liposomes afterwards as
an ethanolic solution (about 1 vol.%) on vortexing
followed by the antibody coupling techniques. The
asymmetric distribution of the NBD-PE in these
liposomes could be proven with quenching experi-
ments adding dithionite solution (1 M Tris, pH 10)
in a molar ratio NBD/dithionite 1/25 000.
The internalization studies were performed at 37‡C
for over 90 min following the binding experiments in
the wells described in Section 2.4.1. Afterwards, 75 Wl
of a 1.5 M dithionite solution was added to the wells
for 3 min. Following the washings, the remaining
NBD £uorescence was analysed representing the in-
ternalized fraction.
For endocytosis blocking experiments, cells were
pretreated with either antimycin A (1 Wg/ml), 0.1%
NaN3 or cytochalasin D (20 Wg/ml dissolved in
DMSO and diluted with medium to ¢nal concentra-
tion 6 1%). Depletion of intracellular K was per-
formed as previously described [25] using the hypo-
tonic shock procedure. Medium was removed and
cells were washed three times with bu¡er A (50 mM
HEPES, 100 mM NaCl, pH 7.4) and incubated in
hypotonic medium (medium/water 1:1) followed by a
10-min incubation in bu¡er A.
For dithionite experiments with microscopic detec-
tion, 500 000 HUVEC were cultivated onto slides for
3 h followed by an activation. Liposomes were added
for 90 min at 37‡C and images were taken after re-
moving unbound liposomes and after dithionite re-
duction.
2.5.2. Pyranine assay
The absorbance characteristics of a 60 mM solu-
tion of HPTS were ¢rst analysed between 200 and
500 nm (emission 512 nm) in a pH range from 5.5 to
BBAMEM 78136 31-8-01 Cyaan Magenta Geel Zwart
S. Kessner et al. / Biochimica et Biophysica Acta 1514 (2001) 177^190180
8.5 (Fluorimeter Hitachi Fluoroscan), in order to
detect the spectroscopical changes in HPTS during
acidi¢cation within the endosomes/lysosomes. For
the endocytosis assay, liposomes were prepared in a
35 mM HPTS solution, whereas HPTS outside the
liposomes was replaced by gel chromatography
(Sephadex G50) eluted with PBS followed by an anti-
body conjugation. For the cell experiments, about
106 HUVEC (activation afterwards), keratinocytes
as negative control and J774 as positive control
were transferred into dishes. After cell adherence,
2 Wmol of liposomes were added and incubation oc-
curred at either 4‡C or 37‡C. After several washings,
cells were removed from the dishes and placed in
cuvettes for absorbance measurements (405, 416
and 460 nm). An acidi¢cation due to endocytotic
uptake was evaluated because of an increase in the
405/416 nm quotient with a simultaneous decrease of
the 460/416 nm quotient.
2.5.3. Microscopic investigation of double-labelled
liposomes
In order to follow the path of liposomes within the
HUVEC and to detect a liposome fragmentation, the
liposomes were labelled twice. Therefore, liposomes
were prepared with incorporated 100 mM calcein as
a soluble label and with 2 mol% Rhodamine-PE as a
membrane marker. HUVEC on glass slides and lipo-
some incubation were handled as described in Sec-
tion 2.5.1. In order to completely remove all lipo-
somes outside the cell (bound and unbound), the
cells were washed several times with a bu¡er fol-
lowed by an incubation period with citric bu¡er
(pH 3.0) for 3 min (acid wash) before washing again
with bu¡er twice. Microscopic detection was per-
formed with the confocal LSM at excitations of
both 488 nm to illustrate the localization of calcein
and 543 nm to detect rhodamine.
2.5.4. Fusion assay using calcein
Liposomes for these experiments were prepared in
100 mM calcein with the subsequent removal of cal-
cein outside the liposomes by gel chromatography.
HUVEC adherence and activation on glass slides
were performed as described above. Liposomes
were incubated at both 4‡C and 37‡C for 90 min.
After washing and an ‘acid wash’, microscopic im-
ages were taken at excitation of 488 nm.
3. Results and discussion
3.1. Immunoliposome targeting under dynamic
conditions
In a previous study, we demonstrated that target-
ing IL to E-Selectin is a promising way to achieve
drug delivery at in£ammatory sites [17]. Further-
more, it was evident that liposomes with antibodies
coupled to the terminal ends of PEG as with our
newly established ‘Cyanur-PEG-PE IL’ had a much
higher targetability [22]. These in vitro experiments
were performed under static conditions, which do
not adequately simulate the physiological situation.
In order to follow the fate of targeted liposomes and
to obtain therapeutical advancements from this be-
haviour, physiological relevant information about
the ability and duration of the binding are necessary.
Therefore, we applied a £ow chamber system, allow-
ing IL to interact with a HUVEC monolayer out of
the streaming medium at a physiological shear rate
of 200 s31. The binding of NBD-labelled liposomes
could continuously be documented by microscopical
images in a period of about 18 h, which is relevant
for immunoliposome circulation in vivo.
To evaluate these results with respect to HUVEC
activation (E-Selectin expression) and type of IL, we
either prepared conventional IL containing 5 mol%
PEG-PE 2000 coupled with the anti-E-Selectin mAb
BBA 26 at N-Glut-PE, or terminally coupled Cya-
nur-PEG-PE (5 mol%) IL and analysed their bind-
ings at both activated and non-activated HUVEC.
As a control experiment, plain liposomes do not
bind HUVEC under £ow, neither with activated nor
non-activated cells. On the other hand, both types of
IL are able to bind the HUVEC out of the streaming
medium, and with time the binding intensity in-
creases cumulative. Despite the Cyanur-PEG-PE IL
have a slightly lower degree of coupled antibodies
(about 35 Wg/Wmol phospholipid corresponding to
about 25 antibodies/liposome versus 49 Wg/Wmol or
30 antibodies/liposome for the N-Glut-PE prepara-
tions); however, they have a slightly higher target-
ability which is attributed to the better accessibility
of the mAb. As illustrated in Fig. 1, nearly no bind-
ing occurs at inactivated HUVEC, demonstrating the
speci¢city of binding via the E-Selectin.
These binding studies prove that both types of IL
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Fig. 1. Binding of NBD-labeled Cyanur-PEG-PE IL with E-Selectin mAb BBA26 onto stimulated HUVEC under shear force conditions after 10 min, 5 h and
18 h (upper line from left) compared to the binding toward non-stimulated HUVEC after 18 h (right, low).
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are able to target E-Selectin under shear stress in a
circulation- and therapy-relevant time range. Because
binding resists the shear forces for a su⁄ciently long
time, the fate of liposomes should be analysed fur-
ther for achieving a therapeutical drug e¡ect.
3.2. Determination of the cellular uptake of liposomes
by HUVEC
Following the fate of liposomes after targeting the
HUVEC, a cellular uptake of the liposomes would be
desirable since this o¡ers the most potential for drug
or gene therapy. Several ways of liposome uptake
exist which can be analysed by di¡erent spectroscop-
ical or microscopical means. We ¢rst wanted to select
an analytical technique which illustrates a general
uptake of intact liposomes, which clearly distin-
guishes between surface bound and incorporated
liposomes by £uorescence spectroscopy for quanti¢-
cation and microscopy for qualitative evaluation. We
therefore chose the so-called dithionite technique
where the £uorescence of NBD-labelled liposomes
were quenched by chemical reduction induced by di-
thionite [26]. Since dithionite cannot permeate the
cell membrane, liposome quenching occurs only out-
side the cells. Therefore, this technique o¡ers excel-
lent prerequisites for correlating the cellular uptake
of liposomes with their cell-binding ability when con-
sidering the type of IL (conventional versus termi-
nally coupled), sterical stabilization or the role of
the coupled antibodies.
Since dithionite cannot permeate bilayers, the lipo-
somes have to be only labelled in the outer mono-
layer. We performed this by adding an ethanolic so-
lution of NBD-PE to the preformed liposomes before
coupling the antibodies. In order to prove the NBD-
orientation and to quantify the NBD quenching, we
added a dithionite solution to these liposomes. As
illustrated in Fig. 2, nearly 75% of NBD-£uorescence
was quenched within the ¢rst 10 s increased to about
90% within the next 5 min, which con¢rms an asym-
metric NBD distribution in the liposomes.
In order to compare liposome binding and cellular
uptake in one experiment, we added liposomes to
activated HUVEC for 60 min at 4‡C (no active in-
ternalization) and after several washings, their inter-
nalization at 37‡C for 90 min was studied. The
amount of liposomes added was previously opti-
mized and kept constant at 150 nmol/40 000 HUVEC
per well, representing about 2U1012 liposomes or
5U107 liposomes per cell.
To demonstrate the speci¢city of binding via
E-Selectin and cooperation with the internalizing fac-
tors, we prepared conventional (N-Glut-PE) IL with
and without sterical stabilization by 5 mol% PEG
2000 and terminal-coupled Cyanur-PEG-PE IL,
each as plain liposomes, coupled with irrelevant
IgG or with selectin-speci¢c IgG (BBA 26). As
shown in Fig. 3A, the PEG-free N-Glut-PE lipo-
somes with BBA 26 bind strongly to activated
HUVEC, regarded as relative 100% £uorescence cor-
responding to about 5U108 liposomes per well or
12 500 per HUVEC. This value should in part be
attributed to unspeci¢c liposome adherence, since
the addition of PEG drastically reduces the amount
of bound liposomes. Both data represent the specif-
icity of binding via E-Selectin, whereas the coupled
irrelevant antibodies are without e¡ect since these
liposomes behave like plain ones. Despite the same
sterical stabilization, the Cyanur-PEG-PE liposomes
have a much higher targetability, attributed to their
exposed antibody position. Non-stimulated HUVEC
were used for the control, the binding of all three
BBA 26 IL was depressed to blank levels (not
shown).
When evaluating the corresponding liposome in-
ternalization in Fig. 3B, the PEG-free N-Glut-PE
preparation with the speci¢c BBA 26 antibody was
again regarded as relative 100%. The absolute £uo-
rescence and the corresponding number of liposomes
Fig. 2. Time course of £uorescence quenching after adding di-
thionite solution to liposomes containing 2 mol% NBD-PE in
the outer monolayer (molecular ratio NBD/dithionite 1:25 000).
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(1.25U108 or 3100 per HUVEC) demonstrate that
about 25% of targeted liposomes were internalized.
This ratio is nearly true for all of the investigated
preparations, regardless of the presence or the spe-
ci¢city of the coupled antibodies. When considering
the non-complete dithionite quenching of NBD (Fig.
2) outside the cell which yielded slightly increased
internalization data, it can be concluded that in all
cases about 20^25% of bound liposomes were inter-
nalized. This fact speaks against an active, internal-
izing role of E-Selectin, otherwise all three BBA 26
preparations would have a much more distinct devi-
ation from the others. Furthermore, the presentation
of IgG is also not an internalizing factor, which
could be explained due to a postulated internalizing
IgG-receptor [27]. The slightly increased internaliza-
tion of the Cyanur-PEG-PE liposomes is not easy to
interpret.
Also in relationship to other studies, the internal-
ization capacity seems to be low, since Mastrobattis-
ta et al. report about a sixty percent uptake of
ICAM-targeted IL by epithelial cells [18].
To look for the uptake mechanisms, we modi¢ed
the experimental conditions. Firstly by ¢xing the
HUVEC with formaldehyde, active internalization
was prevented. We obtained identical binding data
of the liposomes at both living and formaldehyde-
¢xed HUVEC (data not shown), therefore, the cor-
responding internalization data are well to compare.
The passive internalization capacity (Fig. 3C) is ap-
proximately 40^70% of the total internalization. The
degree of reduction indicated no correlation to lipo-
somal features. In general one can conclude that the
liposomal uptake is mediated by active and passive
processes, both are comparable in their intensities.
Dithionite addition immediately after the 4‡C period
shows a non-complete £uorescence quenching which
indicates that a part of liposomes has already been
taken up by the cells under these conditions, neces-
sarily on a passive way.
In conclusion, we can state that about 25% of the
targeted liposomes were internalized by stimulated
C
Fig. 3. Binding and internalization of NBD-labeled immunoli-
posomes by stimulated HUVEC. Immunoliposomes with the E-
Selectin mAb BBA26 were N-Glut-PE-coupled (conventional
IL) without PEG-PE 2000 (left group), with 5 mol% PEG-PE
2000 (middle group) and Cyanur-PEG-PE-(terminally coupled)
IL (right group), each compared to plain liposomes and IL
coupled with irrelevant mAb. Data are means of at least four
experiments þ S.D. (A) Liposome binding onto stimulated HU-
VEC after 60 min at 4‡C. Binding data are expressed as relative
£uorescence, regarding the conventional PEG-free preparation
with BBA 26 as 100%. (B) Internalization of the bound lipo-
somes (A) by stimulated HUVEC after 90 min at 37‡C detected
by NBD-quenching with dithionite. Data are expressed as rela-
tive £uorescence related to conventional PEG-free preparation
with BBA 26 as 100%. (C) Corresponding liposome internaliza-
tion data after ¢xing the HUVEC with formaldehyde.
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endothelial cells. Active as well as passive mecha-
nisms are involved in internalization, and a correla-
tion between liposome functionalization and inter-
nalization is not evident.
3.3. Characterization of active liposome
internalization
To de¢ne the mechanisms involved in the active
internalization of the liposomes, HUVEC were pre-
treated with di¡erent chemical agents that interfere
with various aspects of the uptake process. Cytocha-
lasin D is known to disrupt the micro¢lament net-
work by inhibiting actin polymerization and thereby
blocking phagocytosis and pinocytosis, but not re-
ceptor-mediated endocytosis [28]. Antimycin A as
well as a mixture of formaldehyde and NaN3 restrict
the metabolic activity of cells and thus inhibit both
receptor- and non receptor-mediated endocytosis
[29,30]. Cell depletion of K inhibits the receptor-
mediated endocytosis by removing clathrin from
the plasma membrane [25,31]. The blocking experi-
ments were performed with the PEG-free conven-
tional IL as representatives, again using plain lipo-
somes and irrelevant IL for control.
Internalization data in the presence of di¡erent
blocking agents are illustrated in Fig. 4 which clearly
demonstrate that phagocytosis is important for blank
liposomes but plays only a minor role in the internal-
ization process of the speci¢c IL. Cytocalasin reduces
the uptake of the previous ones by about 45%,
whereas speci¢c IL are reduced by about 15%. The
metabolic inhibitors antimycin or formaldehyde/
NaN3 considerably decrease the liposome uptake,
which in general con¢rms the data from Fig. 3C
and the fact that internalization results, in part,
from endocytosis. The most interesting data came
from cell depletion of K. Whereas the control lipo-
some uptake is not a¡ected by this treatment, the
entry of the selectin-directed IL is drastically reduced
to the level of the blanks which indicates that only
speci¢c liposomes were taken up by a receptor-medi-
ated process. Despite the fact that the percentage of
internalization versus the binding is comparable be-
tween blanks and selectin-directed IL, these ¢ndings
clearly indicate the di¡erent mechanisms of uptake.
Whereas when the speci¢c IL were taken up by a
receptor-mediated process, blank liposomes were
most likely internalized on other endocytic routes
like phagocytosis or by caveolae. Furthermore, these
data con¢rm that the internalizing role of selectins
seems to be relatively low as outlined in Fig. 3B.
In order to procure optical evidence for cellular
liposome incorporation, we studied targeted stimu-
lated HUVEC after dithionite addition by confocal
£uorescence microscopy. A z-scan through the cell in
Fig. 5 provides clear evidence for an intracellular
localization of the liposomes. They appear as £uo-
rescent spots in discrete areas which might be endo-
somal vesicles.
3.4. Evaluation of the intracellular route of liposome
using HPTS
In order to follow the intracellular fate of lipo-
somes we applied an endocytosis assay based on
the pyranine dye HPTS. HPTS is a well-established,
membrane-impermeant and pH-dependent £uoro-
phore, that emits maximally at 512 nm after excita-
tion at 405 nm in acidic medium or at 460 nm in
neutral environment [32]. Therefore, the endocytotic
uptake of HPTS-loaded liposomes with subsequent
acidi¢cation of the dye in the endosomes can be
characterized by spectral changes. The overlay of
HPTS spectra at di¡erent pH displays a pH-inde-
pendent (isosbestic) point at 416 nm. Consequently,
increasing quotients of 405/416 nm and decreasing
460/416 nm absorbance detect a drop in pH during
liposome incorporation in a concentration independ-
Fig. 4. Internalization of bound conventional IL without PEG-
PE 2000 and their blank analogues after 90 min at 37‡C by
stimulated HUVEC, which have been pretreated with several
agents that interfere with di¡erent routes of an endocytotic
pathway. Data represent mean þ S.D. (n = 4).
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ent manner and con¢rm an endocytotic liposome
uptake.
In order to illustrate the applicability of this tech-
nique, we studied the interaction of plain HPTS-
loaded liposomes with control cells that either dis-
played a high degree or no ability for endocytosis.
Incubation the liposomes with the highly endocytic
macrophage cell line J774 at 37‡C for 2 h led to a
dramatic increase in the 405/416 (Fig. 6A) and a
strong decrease in the 460/416 nm ratio (Fig. 6B),
which is attributed to a strong endocytotic liposome
uptake. In contrast, keratinocytes as a negative con-
trol showed absolutely no change in the 405/416 nm
ratio and only a marginal shift in the 460/416 nm
ratio within 5 h, attributed to no endocytotic activ-
ity.
Incubating the HUVEC with either the blank or
the speci¢c IL for up to 5 h at 37‡C demonstrates
that neither the plain liposomes nor the IL with the
irrelevant antibodies provide data that can be inter-
preted for endocytosis. Only in the case of the selec-
tin-directed IL, by slightly increasing 405/416 nm
(Fig. 6A) and by decreasing 460/416 nm absorbance
(Fig. 6B), a low but clearly detectable liposomal ap-
pearance in the endosomes could be demonstrated.
These ¢ndings might con¢rm the di¡erences in the
uptake mechanisms.
These di¡erences may also be a result from the
Fig. 5. Confocal laser scanning microscopic images (z-scan) through a stimulated single HUVEC targeted with NBD-PE-labeled con-
ventional BBA 26-IL after £uorescence quenching (dithionite) outside the cell.
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sensitivity of the HPTS assay. The speci¢c IL have
the highest binding rate and consequently the highest
absolute internalization, which might be detectable
by HPTS while not for the other liposomes.
In general, these experiments con¢rm that the spe-
ci¢c IL were taken up by endocytosis and appear in
the endosomes. The HPTS assay does not allow an
exact quanti¢cation of this process.
3.5. Detection of liposomal fusion with the cells by
calcein release
In order to characterize passive liposome cell in-
teractions we searched for liposomal fusion with the
cell membrane. A common technique to follow this
process is analysing the release of entrapped £uores-
cent dyes such as calcein. We again chose the PEG-
free conventional IL with incorporated calcein at
self-quenching concentrations (100 mM) as represen-
tatives and studied their cell interaction by £uores-
cence microscopy. Intracellular £uorescence might
either be caused by liposomal fusion with the cell
membrane and calcein release into the cytosol or
by intact uptake of the liposomes with subsequent
Fig. 7. Interaction of calcein-loaded conventional IL without
PEG-PE 2000 with stimulated HUVEC for 90 min. At 4‡C
(upper image), calcein £uorescence is homogeneously distributed
within the cell, attributed to liposomal fusion with the cell
membrane. The £uorescence spots in the 37‡C image (lower im-
age) demonstrate an endocytotic liposome uptake in addition to
fusion.
Fig. 6. HPTS-assay to detect the endocytotic uptake of conven-
tional IL by stimulated HUVEC compared to the endocytotic
activity of keratinocytes or a macrophage cell line (n = 3). Both
the increase of the £uorescence ratio 405/416 nm (A) and the
decrease of the £uorescence ratio 460/416 nm (B) are indicative
as signal for an endocytotic uptake of HPTS-loaded liposomes.
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degradation in the endosomal compartments. Both
processes may be di¡erentiated by temperature, at
4‡C only the passive fusion process occurs, whereas
studies at 37‡C detect both fusion and active lipo-
somal uptake. Therefore, we incubated the calcein
liposomes with the HUVEC simultaneously at 4‡C
and 37‡C for 90 min, after thoroughly replacing sur-
face-bound liposomes by ‘acid wash’ [33] microscopic
images were taken.
At 4‡C (Fig. 7, upper) a certain amount of calcein
is released homogenously within the cytosol, attrib-
uted to fusion of the liposomes with the cells. This
¢nding might be unexpected since normally lipo-
somes should not fuse with cells without trigger
mechanisms. Because we could con¢rm that this re-
sult is not an artefact from cell handling or liposome
incubation (no release of calcein outside the cell with
subsequent uptake of the free dye), fusion might be
interpreted in terms of the missing sterical protection
of these liposomes by PEG. Furthermore, no studies
about liposome fusion with endothelial cells are
available for comparison. The lower image in Fig.
7 illustrates the behaviour at 37‡C, where addition-
ally to fusion endocytosis may occur. This picture is
dominated by a spot-like distribution of calcein with-
in the cells, demonstrating the localization of calcein
within intracellular vacuoles, which are most likely
endosomes. Plain liposomes and those coupled with
unspeci¢c antibodies behave similar to the speci¢c
IL.
These studies give an qualitative insight into the
liposomal fusion process, but do not allow a quanti-
¢cation. Considering the passive liposome internal-
ization (Fig. 3C), it is not reasonable that these
data are solely caused by fusion.
An additional evidence for liposome fusion is the
Fig. 8. Interaction of Rhodamine-PE- labelled and calcein-loaded conventional IL (without PEG-PE 2000) with stimulated HUVEC
for 90 min at 37‡C. Both labels were simultaneously detected (upper images); the superimposed picture of both ¢lter settings resulting
in orange is illustrated in the lower image to demonstrate the co-localization of the markers.
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transfer of lipophilic markers from the liposomes to
the cell membrane. Moreover, when combining a lip-
ophilic label with an entrapped marker, which di¡er
in their spectral characteristics, fusion can exactly be
detected by separated localization of both markers,
whereas a colocalization indicates the appearance of
intact liposomes within the cell. Therefore, we used
liposomes containing both Rhodamine-PE, as lipo-
philic label, and calcein. In order to detect simulta-
neously fusion and endocytosis, liposomes were in-
cubated with HUVEC at 37‡C for 90 min and
analysed after an acid wash. The rhodamine £uores-
cence in Fig. 8 appears homogeneously along the cell
surface, which might be indicative for fusion. The
rhodamine spots within the cell are similar to Fig.
7 (37‡C) were interpreted as the accumulation in vac-
uoles. The calcein spots with an analogue location
are dominant which further con¢rms the appearance
of vesicles inside of cellular compartments. This also
becomes evident by superimposing both pictures,
which results in orange spots. However, after desorb-
ing external liposomes, no co-localization was detect-
able along the cell body. This separated localization
of rhodamine in the cell membrane and calcein in the
cytosol can be interpreted as a result of fusion.
In summary, the use of double-labelled liposomes
con¢rms the calcein release experiments and demon-
strates that IL tend to fuse with the cell membrane,
whereas most of the liposomes were accumulated
within the cell as a result of an active uptake.
4. Conclusions
E-Selectin-directed IL are regarded as very attrac-
tive vehicles to accumulate drugs at sites of in£am-
mation. In the present study, we demonstrated that
the IL are able to bind at interleukin-1-activated hu-
man endothelial cells (HUVEC) under simulated
shear force conditions of the capillary blood £ow.
Binding is selectin-speci¢c and does not occur on
unstimulated cells. Since bound liposomes resist the
£ow for a therapy-relevant time, the fate of lipo-
somes at the target site has to be evaluated to pro-
cure a therapeutical bene¢t from this behaviour. In
this study, we analysed the liposomal uptake by the
HUVEC with four di¡erent spectroscopical and mi-
croscopical methods.
To date, only a few studies have investigated the
liposome uptake by endothelial cells. It is very di⁄-
cult to compare our studies to these investigations
because of the di¡erent origins of the endothelial
cells. Nothing is known about the internalizing role
of E-Selectin after targeting, whereas after activation
E-Selectin on its own is replaced from the cell surface
by endocytosis or by shedding [34].
To evaluate the in£uence of liposomal parameters
on internalization, we used conventional IL with and
without sterical stabilization, as well as IL with PEG-
terminal coupled antibodies.
Despite a strong di¡erentiated surface binding
among the liposomes, with superiority being deter-
mined in terminal coupled ones, a constant fraction
of about 25% of bound liposomes was taken up by
the HUVEC for all types of liposomes. The domi-
nant mechanism of liposome uptake is endocytic.
Only the selectin-directed IL were be taken up by
receptor-mediated endocytosis, whereas other lipo-
somes were most likely ingested by phagocytosis.
The appearance of the speci¢c IL in the endosomal
compartments after internalization could be demon-
strated with the HPTS assay. The internalizing activ-
ity was directly attributed to E-Selectin and is con-
sidered relatively low. However, despite the similar
internalization percentage of all of the bound lipo-
somes, the much higher binding rate of the selectin-
targeted IL leads to a considerable drug accumula-
tion within the cell. Therefore, selectin targeting of
IL toward the endothelium seems to be a suitable
mode for intracellular tra⁄cking of agents or as a
basis for gene therapy which fundamentally enhances
antiin£ammatory therapies. This aspect can be em-
phasized further by the fact that the non-sterically
stabilized liposomes fuse with the cell membrane
and subsequently release liposomal content into the
cytoplasm.
However, it must be kept in mind that despite
successful liposomal internalization after targeting
toward selectins, these liposomes have to be opti-
mized for therapeutical means. An important aspect
to modify the lipid composition of these liposomes is
the avoidance of lysosomal degradation by creating
pH-sensitive IL. These studies are currently under
investigation.
In conclusion, when considering the internalization
capacity of the targeted endothelial cells, a controlled
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release of drugs out of the liposomes in the course of
targeting and a subsequent uptake of the free drug
might also be discussed as alternative.
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